Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04280549 · ClinicalTrials.gov registry record
Platelet PAR-1 Activation in Health and Diabetes
A clinical trial, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 100
- Enrollment target
NCT04280549 is a clinical trial that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 100 participants.
The verdict
NCT04280549 has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
Platelet activation has been associated with bad events like heart attack and stroke. There are a variety of platelet activators that regulate how active a platelet is. We are interested in Protease-activated receptors (PAR)-1. We are currently studying PAR-1 activation in persons with severe peripheral artery disease. We seek, through this project, to understand PAR-1 activation in persons without peripheral artery disease. As many patients with peripheral artery disease have diabetes, we will also evaluate PAR-1 activation in persons with type 2 diabetes. In addition we will assess the impact of the glucagon-like peptide (GLP)-1 signaling pathway on platelet activation. Levels of platelet activation will be determined using platelet aggregation experiments and assessment of platelet-monocyte aggregates in peripheral blood.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2018-06-01 |
| Est. Completion | 2021-02-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04280549
The ClinicalTrials.gov registry entry for NCT04280549 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04280549 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04280549 about?
NCT04280549 is a clinical study titled "Platelet PAR-1 Activation in Health and Diabetes". Platelet activation has been associated with bad events like heart attack and stroke. There are a variety of platelet activators that regulate how active a platelet is. We are interested in Protease-activated receptors (PAR)-1. We are currently studying PAR-1 activation in persons with severe periph...
What is the current status of trial NCT04280549?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2018-06-01. Estimated completion is 2021-02-02.
Who is sponsoring clinical trial NCT04280549?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.